CNS Pharmaceuticals posts investor video on Berubicin trial

CNS Pharmaceuticals, Inc.

CEO John Climaco discusses Berubicin clinical trial in Virtual Investor event.
Event link posted on October 18, 2023; no financial data or trial results disclosed in 8-K.
No specific quantitative updates or forward guidance provided in the filing.

item 7.01

CNS Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-007238

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.